A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Clinical trial NCT05035082 · COMPLETED
Trial details
- NCT number
- NCT05035082
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2025-06-18
- Enrollment
- 1018
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.